Royal Women's Hospital
Royal Women's Hospital
Parkville, Victoria, Australia4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sentinel Node Biopsy in Endometrial Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 3 | 2026-09-15 | NCT04073706 | |
| A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, female reproductive system disorder, female reproductive system neoplasm, neoplasm, vulva cancer, vulvar disease | Not yet recruiting | Phase 3 | 2026-03-24 | NCT06476639 | |
| Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Fetal Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, fetal growth restriction, hereditary endocrine growth disease, pregnancy disorder, pregnancy disorder with abortive outcome | Recruiting | Phase 3 | 2025-06-06 | NCT05651347 | |
| The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, asthma, atopic eczema, bronchial disorder, dermatitis, food allergy, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder, skin disorder | Active, not recruiting | Phase 3 | 2023-05-10 | NCT03667651 |